Global Autoinjectors Market Research Report 2023
Autoinjectors Market Size By Product Type (Disposable, Reusable) Application (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Diabetes) Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies) End-Users (Hospitals and Clinics, Homecare Settings) And Region Global Market Analysis and Forecast, 2023-2030
Autoinjectors Market Synopsis
The Global Autoinjectors Market size was reasonably estimated to be approximately USD 50900 Million in 2023 and is poised to generate revenue over USD 168200 Million by the end of 2030, projecting a CAGR of around 21.40% from 2023 to 2030.
Autoinjectors are medical devices that allow people to easily and accurately self-administer pre-measured doses of medication. They improve ease of use, promote medication adherence and give patients the option to manage treatment at home. Autoinjectors simplify drug administration, making it easier and more effective for patients with chronic diseases.
- The autoinjector market is a rapidly growing segment in the healthcare industry. Autoinjectors are medical devices designed to administer a pre-measured dose of medication by self-injection. They are mainly used to treat chronic diseases such as rheumatoid arthritis, multiple sclerosis, anaphylaxis and diabetes.
- One of the factors driving the growth of the autoinjectors market is the increasing prevalence of chronic diseases across the globe. As the number of patients requiring long-term medication increases, there is a growing demand for user-friendly and convenient drug delivery systems, where auto-injectors play a crucial role. With the help of autoinjectors, patients can easily and accurately administer their medication, which improves compliance and overall treatment outcomes.
- Another important factor driving the growth of the market is the focus on home care and self-administration of medicines. Auto-injectors allow patients to administer medications from the comfort of their own homes, reducing the need for frequent visits to healthcare facilities. This trend is particularly visible in diseases such as diabetes, where patients require regular insulin injections.
- The autoinjector market is also affected by the rise in allergies and the increase in demand for first aid. Auto-injectors containing epinephrine are widely used for the immediate treatment of severe allergic reactions such as anaphylaxis. This segment is expected to grow significantly due to increasing awareness of allergies and the importance of prompt treatment.
Top Key Players Involved Are:
"Amgen Inc. (US), Merck KGaA (Germany), Mylan N.V. (US), Novartis International AG (Switzerland), Pfizer Inc. (US), Sanofi S.A. (France), Antares Pharma Inc. (US), Haselmeier AG (Switzerland), Consort Medical plc (UK), SHL Group (Taiwan), Gerresheimer AG (Germany), SCHOTT AG (Germany), Biogen Inc. (US), Roche Holding AG (Switzerland), UCB S.A. (Belgium), GlaxoSmithKline plc (UK), Bayer AG (Germany), Boehringer Ingelheim International GmbH (Germany), Mitsubishi Tanabe Pharma Corporation (Japan), Eli Lilly and Company (US) and Other Major Key Players."
The Autoinjectors Market Trend Analysis
Surging Demand for Allergy Autoinjectors
- The growing awareness of severe allergies and the need for first aid has led to a significant increase in the demand for allergy auto-injectors. These auto-injectors quickly and efficiently deliver life-saving medications such as epinephrine during severe allergic reactions such as anaphylaxis.
- Increased allergy awareness is driving the demand for anti-allergy auto-injectors, which at-risk individuals are seeking as a precaution. Schools, workplaces and public spaces are also adopting automatic injectors in emergency preparedness.
- Auto-injectors are useful for allergy management because they are easy to use and allow self-administration in emergencies. Their compact and portable design allows quick access to life-saving medications when needed. The growing demand for anti-allergy auto-injectors underlines their important role in reducing the risks associated with severe allergic reactions and saving lives.
The Aging Population Boosts Autoinjector Demand
- An ageing population increases the demand for auto-injectors as the elderly need assistance in administering medications. Autoinjectors offer a convenient and user-friendly solution to drug delivery problems such as dexterity and cognitive impairment. They ensure accurate dosing and improve medication adherence in the elderly.
- Autoinjectors provide caregivers of elderly patients with an easy and safe way to administer medications that require little medical preparation. The convenience, safety features and portability of autoinjectors provide peace of mind for both caregivers and patients. This makes auto-injectors an ideal solution for administering medication to the ageing population at home and in assisted living.
- An ageing population presents a significant market opportunity for auto-injectors. These devices solve the medication management issues faced by seniors and caregivers and provide a convenient solution for managing chronic diseases and improving adherence in this population.
Segmentation Analysis Of The Autoinjectors Market
Autoinjectors market segments cover the Product Type, Application, Distribution Channel, and End-Users. By Application, the Rheumatoid Arthritis segment is Anticipated to Dominate the Market Over the Forecast period.
- Autoinjectors are essential in the treatment of rheumatoid arthritis (RA) and deliver precise doses of medication directly into the body. They offer comfort, precision and better treatment results for patients with rheumatoid arthritis.
- Auto-injectors offer convenient and user-friendly self-administration of medication for people with rheumatoid arthritis (RA). They allow patients to manage their medication at home, which improves compliance and reduces the need for repeat doctor visits.
- Rheumatoid arthritis autoinjectors ensure accurate dosing, minimize needle stick injuries and include safety features that improve the injection experience and reduce discomfort.
Regional Analysis of The Autoinjectors Market
North America is Expected to Dominate the Market Over the Forecast Period.
- The North American car injector market is a significant and thriving segment in the healthcare industry. The region includes the United States and Canada, which have established health systems and a significant prevalence of chronic diseases.
- Factors driving the growth of the North America autoinjectors market are the increasing prevalence of chronic diseases such as rheumatoid arthritis and multiple sclerosis, which require long-term drug therapy.
- The region is characterized by a strong presence of pharmaceutical companies and medical device manufacturers that develop and market autoinjectors. Technological advances, regulatory support and strong distribution networks continue to stimulate market growth.
- North America continues to make significant investments in research and development, product innovation and strategic collaborations to meet the changing needs of patients and healthcare providers.
Covid-19 Impact Analysis On Autoinjectors Market
- The COVID-19 pandemic has harmed the car sprinkler market. First, disruptions in the global supply chain and manufacturing processes caused delays in the production and distribution of automotive injectors. International trade restrictions, embargoes and labour restrictions have hindered the smooth movement of raw materials and components, which has affected the overall availability of automotive injectors in the market.
- The COVID-19 pandemic has changed health priorities, leading to the postponement or cancellation of unnecessary medical appointments and procedures. This led to a decline in demand for auto-injectors, as patients with chronic illnesses had trouble accessing health care and obtaining conventional medications, including auto-injectors.
- In addition, the financial uncertainty caused by the pandemic has affected the affordability of health products, including auto-injectors. Job losses, financial pressures and changes in insurance coverage have created barriers for patients to access and obtain the medications and medical equipment they need.
Top Key Players Covered in The Autoinjectors Market
- Amgen Inc. (US)
- Merck KGaA (Germany)
- Mylan N.V. (US)
- Novartis International AG (Switzerland)
- Pfizer Inc. (US)
- Sanofi S.A. (France)
- Antares Pharma Inc. (US)
- Haselmeier AG (Switzerland)
- Consort Medical plc (UK)
- SHL Group (Taiwan)
- Gerresheimer AG (Germany)
- SCHOTT AG (Germany)
- Biogen Inc. (US)
- Roche Holding AG (Switzerland)
- UCB S.A. (Belgium)
- GlaxoSmithKline plc (UK)
- Bayer AG (Germany)
- Boehringer Ingelheim International GmbH (Germany)
- Mitsubishi Tanabe Pharma Corporation (Japan)
- Eli Lilly and Company (US)
Key Industry Developments in the Autoinjectors Market
In May 2023, Amgen and TScan Therapeutics collaborated to identify antigens recognized by T cells in patients with Crohn's disease. TScan will receive a $30 million upfront payment and could earn more than $500 million in milestone payments in addition to royalties. The partnership aims to use TScan's TargetScan target discovery platform to advance Crohn’s disease research.
In June 2023, Novartis announced the acquisition of S Chinook Therapeutics. The deal expands Novartis' kidney portfolio by adding two drugs for rare late-stage chronic kidney disease. This acquisition is in line with Novartis' strategy to focus on innovative medicines and strengthen its presence in the kidney space. The contract is subject to normal closing conditions.
|
Global Autoinjectors Market |
|||
|
Base Year: |
2022 |
Forecast Period: |
2023-2030 |
|
Historical Data: |
2016 to 2021 |
Market Size in 2023: |
USD 50900 Mn. |
|
Forecast Period 2023-32 CAGR: |
21.40% |
Market Size in 2030: |
USD 168200 Mn. |
|
Segments Covered: |
By Product Type |
|
|
|
By Application |
|
||
|
By Distribution Channel |
|
||
|
By End Users |
|
||
|
By Region |
|
||
|
Global Autoinjectors Market |
|||
|
Base Year: |
2022 |
Forecast Period: |
2023-2030 |
|
Historical Data: |
2016 to 2021 |
Market Size in 2023: |
USD 50900 Mn. |
|
Forecast Period 2023-32 CAGR: |
21.40% |
Market Size in 2030: |
USD 168200 Mn. |
|
Segments Covered: |
By Product Type |
|
|
|
By Application |
|
||
|
By Distribution Channel |
|
||
|
By End Users |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Product Type
3.2 By Application
3.3 By Distribution Channel
3.4 By End-Users
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological
Frequently Asked Questions
What would be the forecast period in the Autoinjectors Market research report?
The forecast period in the Autoinjectors Market research report is 2023-2030.
Who are the key players in Autoinjectors Market?
Amgen Inc. (US), Merck KGaA (Germany), Mylan N.V. (US), Novartis International AG (Switzerland), Pfizer Inc. (US), Sanofi S.A. (France), Antares Pharma Inc. (US), Haselmeier AG (Switzerland), Consort Medical plc (UK), SHL Group (Taiwan), Gerresheimer AG (Germany), SCHOTT AG (Germany), Biogen Inc. (US), Roche Holding AG (Switzerland), UCB S.A. (Belgium), GlaxoSmithKline plc (UK), Bayer AG (Germany), Boehringer Ingelheim International GmbH (Germany), Mitsubishi Tanabe Pharma Corporation (Japan), Eli Lilly and Company (US) and other major players.
What are the segments of the Autoinjectors Market?
The Autoinjectors Market is segmented into Product Type, Application, Distribution Channel, End-Users and Region. By Product Type, the market is categorized into Disposable, and Reusable. By Application, the market is categorized into Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, and Diabetes. By Distribution Channel, the market is categorized into Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies. By End-user, the market is categorized into Hospitals and Clinics and Homecare Settings. By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia Pacific (China; India; Japan; South Korea; Malaysia; Thailand; Vietnam; The Philippines; Australia; New-Zealand; Rest of APAC), Middle East & Africa (Turkey; Bahrain; Kuwait; Saudi Arabia; Qatar; UAE; Israel; South Africa), South America (Brazil; Argentina; Rest of SA)
What is the Autoinjectors Market?
Autoinjectors are medical devices that allow people to easily and accurately self-administer pre-measured doses of medication. They improve ease of use, promote medication adherence and give patients the option to manage treatment at home. Autoinjectors simplify drug administration, making it easier and more effective for patients with chronic diseases.
How big is the Autoinjectors Market?
The Global Autoinjectors Market size was reasonably estimated to be approximately USD 50900 Million in 2023 and is poised to generate revenue over USD 168200 Million by the end of 2030, projecting a CAGR of around 21.40% from 2023 to 2030.
